Similar Papers

Paper Title
Journal
Date
Author
Abstract P1-19-03: Phase II trial of durvalumab and tremelimumab in the hormone receptor-positive metastatic breast cancer with high tumor mutational burden selected by whole exome sequencing: Korean cancer study group trial (KCSG BR17-04)
Yong Wha Moon ...
Cancer Research | VOL. 82
Yong Wha Moon, et. al.Yong Wha Moon ...
15 Feb 2022
A single-arm phase II trial of palbociclib in combination with tamoxifen as first-line therapy for metastatic hormone receptor-positive breast cancer.
Oana Cristina Danciu ... Pavankumar Tandra
Journal of Clinical Oncology | VOL. 39
Oana Cristina Danciu, et. al.Oana Cristina Danciu ... Pavankumar Tandra
20 May 2021
Abstract PD11-05: PD11-05 Gut microbiome signatures correlate with overall survival among patients receiving eribulin with or without pembrolizumab for hormone receptor-positive metastatic breast cancer
Romualdo Barroso-Sousa ... Laura M Spring
Cancer Research | VOL. 83
Romualdo Barroso-Sousa, et. al.Romualdo Barroso-Sousa ... Laura M Spring
01 Mar 2023
Abstract GS5-06: A U.S. food and drug administration pooled analysis of outcomes of older women with hormone-receptor positive metastatic breast cancer treated with a CDK4/6 inhibitor as initial endocrine based therapy
H Singh ... A Ibrahim
Cancer Research | VOL. 78
H Singh, et. al.H Singh ... A Ibrahim
14 Feb 2018
View more papers

More From: Journal for ImmunoTherapy of Cancer

Paper Title
Journal
Date
Author
What’s in a name? Memory NK cells for cancer immunotherapy
Sean J Judge ... Robert J Canter
Journal for ImmunoTherapy of Cancer | VOL. 13
Sean J Judge, et. al.Sean J Judge ... Robert J Canter
31 Jan 2025
Arginase-1-specific T cells target and modulate tumor-associated macrophages
Evelina Martinenaite ... Mads Hald Andersen
Journal for ImmunoTherapy of Cancer | VOL. 13
Evelina Martinenaite, et. al.Evelina Martinenaite ... Mads Hald Andersen
29 Jan 2025
Rapamycin-resistant polyclonal Th1/Tc1 cell therapy (RAPA-201) safely induces disease remissions in relapsed, refractory multiple myeloma
Binod Dhakal ... Daniel H Fowler
Journal for ImmunoTherapy of Cancer | VOL. 13
Binod Dhakal, et. al.Binod Dhakal ... Daniel H Fowler
28 Jan 2025
Plasma membrane-coated nanoparticles and membrane vesicles to orchestrate multimodal antitumor immunity
Yusuke Ito ... Yuki Kagoya
Journal for ImmunoTherapy of Cancer | VOL. 13
Yusuke Ito, et. al.Yusuke Ito ... Yuki Kagoya
26 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.